𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recurrence of hepatitis C virus infection after orthotopic liver transplantation

✍ Scribed by Paul Martin; Santiago J. Muñoz; Adrian M. Di Bisceglie; Raphael Rubin; Jeanne G. Waggoner; Vincent T. Armenti; Michael J. Moritiz; Bruce E. Jarrell; Willis C. Maddrey


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
375 KB
Volume
13
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non

-A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant recipients were found to have had antibodies to hepatitis C before transplantation. All six patients had possible exposure to hepatitis C through blood transfusion or intravenous drug use. Five of the six patients were positive for antibodies to hepatitis C after 1 yr of follow-up. Two of these patients had clinical and histological evidence of acute viral hepatitis in their allografts. In one patient this led to hepatic injury and dysfunction of two successive grafts. In contrast, none of the twentyeight patients who were seronegative for hepatitis C virus antibodies before transplantation has converted to seropositivity after transplantation despite perioperative blood transfusions. These results suggest that hepatitis C diagnosed serologically recurs in a minority of transplant recipients and that de nouo seroconversion must be uncommon. (HEPATOLOGY 1991; 13:719-721.)


📜 SIMILAR VOLUMES


Early recurrence of hepatitis C virus in
✍ Lydia M. Petrovic 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV

Recurrent and new hepatitis C virus infe
✍ James E. Everhart; Yuling Wei; Heather Eng; Michael R. Charlton; David H. Persin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Chronic infection with the hepatitis C virus (HCV) is the most common reason for liver transplantation. We examined the results of laboratory tests for HCV on a cohort of patients who received a liver transplant between 1990 and 1994 at three large centers. Seven hundred twenty-two recipients and 60

Recurrent hepatic lymphangiomatosis afte
✍ Seong H. Ra; Robert F. Bradley; Michael C. Fishbein; Ronald W. Busuttil; David S 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 453 KB

Hepatic lymphangiomatosis is a rare disease characterized by an abnormal lymphatic proliferation involving the liver alone, liver and spleen, or multiple organs. Hepatic lymphangiomatosis becomes symptomatic secondary to compression or replacement of the normal parenchyma, which can lead to liver fa

Rapidly progressive recurrent hepatitis
✍ Neeraj Saraf; M. Isabel Fiel; Graciela DeBoccardo; Sukru Emre; Thomas D. Schiano 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

Early histological recurrence of hepatitis C after liver transplantation (LT) has a negative impact on patient and graft survival. We report a case of histological recurrence of HCV occurring in the second week after LT. A 75-year-old woman with chronic HCV and hepatocellular carcinoma underwent LT

Recurrent hepatitis C after liver transp
✍ Rosangela Teixeira; Sabrina Pastacaldi; George V. Papatheodoridis; Andrew K. Bur 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views
Recurrent hepatitis C virus infection af
✍ Vargas, Victor ;Krawczynski, Krzysztof ;Castells, Lluis ;Martinez, Nuria ;Esteba 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 137 KB

## Background: The value of immunohistochemical methods to identify hepatitis C virus antigen (HCVAg) in liver tissue has not been established. We have evaluated the significance of HCVAg expression in livers of patients with transplants and recurrent hepatitis C virus (HCV) infection. Methods: Fo